信隆健康：预计2025年净亏损5500万元-8000万元

Core Viewpoint - Xilong Health (002105.SZ) expects a net profit attributable to shareholders of the listed company to be between -80 million and -55 million yuan for 2025, representing a year-on-year decline of 322.52% to 190.48% [1] Financial Performance - The company's operating revenue remained roughly flat compared to the previous year, but losses increased significantly [1] - The expected net profit after deducting non-recurring gains and losses is projected to be between -87 million and -62 million yuan [1] Reasons for Loss Increase - The decline in export revenue due to international market conditions and tariff changes, despite a year-on-year increase in domestic sales [1] - A decrease in gross profit margin due to intense market competition, leading to reduced gross profit [1] - The appreciation of the RMB against the USD by over 2% this year resulted in a decrease in the RMB amount of export revenue, further reducing gross profit, along with an increase in financial expenses due to exchange losses of over 6 million yuan [1] - The price of aluminum, the company's main raw material, increased by approximately 4% during the year, reaching historical highs, which led to a rise in operating costs [1] - The company plans to recognize a single impairment provision of approximately 12 million yuan for long-term equity investments and other receivables based on the valuation of a share transaction for its associate company, Tianteng Power, in 2025 [1]